BUSINESS VENTURE CLINIC
  • Home
  • About
  • Clients
  • Resources
    • Links
    • Videos
  • Blog
  • Contact
    • Clinic Schedule

BLOG POSTS

January 11th, 2021

1/11/2021

0 Comments

 
Managing the Effects of High Power Incentives on the Behavior of Entrepreneurs
 
At the age of 24, American entrepreneur, Ryan Blair sold his first company (SkyPipeline)[1] for twenty-five million dollars. Since he owned 25% of the company, Blair anticipated a big payout from the sale. To Blair’s unfortunate surprise, he learned that he was not projected make any money from it. Blair was enraged when he learned this was not a mistake but a consequence of the venture capital contracts he signed, specifically the anti-dilution and liquidation provisions they contained. In response, Blair threatened to tarnish the company’s reputation and withhold his vote to approve the transaction (his vote was required for the sale to proceed under California law).  Following Blair’s outburst, the company’s board of directors agreed to distribute some of the sale’s profits to Blair however, the amount they agreed to was still low relative to his equity ownership in the company.[2] This scenario illustrates how many entrepreneurs react to the application of high-power incentives.
 
Investors impose high power incentives to transfer considerable risk to from themselves to a start-up’s founders and management (which I collectively refer to as “executives”).Two particularly onerous high-power incentives are full anti-dilution rights and multiple liquidation preferences (similar to those in Blair’s venture capital contracts). Inexperienced entrepreneurs like 24 year-old Blair, often do not appreciate the effects they can have until their application is triggered. Thus, despite initially agreeing to these provisions, executives often feel they were treated unfairly by investors when the effects of high-power incentives take place. As a result, disgruntled entrepreneurs retaliate and engage in strategic behaviors to deliberately harm the company which may harm a start-up.
 
The behaviors of executives are significant to a start-up success and this is recognized by venture capitalists, many of whom attribute the failures (of portfolio companies) they observe to shortcomings in senior management and founders.[3] However, despite the negative effects that high-power incentives can have, they are still commonplace in venture capital contracts. Since venture capitalists still request these terms, I provide suggestions to supplement anti-dilution terms and liquidation preference or otherwise to mitigate their negative effects. I begin by describing each term and the interests they signify.

  1. Defining the Provisions
 (a) Full anti-dilution rights / full-ratchets 
Anti-dilution rights are triggered when securities are issued at a price lower than the investor’s conversion price.  The most dilutive variation of this term is a full anti-dilution right, which adjust the investor’s conversion price to the absolute lowest price at which subsequent stock is issued. This provision enables the preferred stockholder to obtain enough shares to maintain their original equity position in the company by disproportionately diluting common shareholders or other investors who do not invest on a pro-rata basis.[4]

 (b) Multiple liquidation preferences 
Preferred shareholders receive some money on liquidation of the company before anything is paid out to other shareholders. Liquidation preferences may be triggered on a company’s bankruptcy or wind-up.  A multiple liquidation preference provides the investor with a right to receive between one-and-a-half and three times the liquidation price (the original purchase price plus any accrued and unpaid dividends). 
 
    2. Interests Underling the Provisions 
A venture capitalist’s main method of mitigating the risk of their investment is the valuation of an investee company.  However, as venture capitalists often recognize that entrepreneurial over-optimism can result in an exaggerated valuation of the company. Full anti-dilution rights and multiple liquidation preferences are triggered in unanticipated, non-ideal circumstances. Effectively, these terms provide the investor with “downside” protection, mitigating the risks of their investments.[5] With this in mind, I conclude this post by outlining some ways to circumvent the perverse implications of these provisions while satisfying the interests of an investor who may request them.

  1. Proposed Alternatives
 (1) Lowering the company’s valuation: when a venture capitalist proposes these terms, it may be due to their inclination that the valuation proposed by a founder is too high.[6] If a venture capitalist is concerned about an overly-optimistic valuation it may be more prudent for an entrepreneur to lower the valuation of their company (to a reasonable extent), rather than relying on these provisions to fill the valuation gap.
(2) Staging investments: this reduces the amount of capital at risk at any given time and enables the venture capitalist to get more information about the business and management of a corporation before hazarding the full amount of anticipated investments. 

    2.  Managing expectations 
The strategic and retaliatory behavior I noted is closely correlated with deviations from the executives original expectations.[7] If either an anti-dilution right or liquidation preference must be used, a start-up’s executives fully should understand their implications along with the real possibility that they will take effect, from the outset.
​
    3.  Considerations to limit the severity of anti-dilution rights: 
(1) capping the dilution produced by them (for instance, at the point at which it becomes clear that management would have no meaningful stake in the business);
(2) adding a sunset clause so that this right is only effective for a limited time following the investment;
(3) making the right affected by the company’s achievement of certain milestones which themselves ameliorate the risks faced by an investor (i.e. Producing commercial product, generating certain gross revenue etc.), in these circumstances, the anti-dilution right can be affected by altering the formula used to adjust the conversion ratio or even by getting rid of the right all together; and
(4) rather than adjusting the conversion provision to the lowest price given to a subsequent purchaser, consider substituting for a weighted averaging “narrow-based” or “broad-based” formula.
     (a) “broad-based” formula: gives the venture capitalist a conversion ratio that reflects a           per share price equal to the weighted average purchase price of all subsequently issued           and outstanding shares. [8]
     (b) “narrow-based” formula: only takes into account the pricing of the shares being                 adjusted (usually just the venture capitalist’s preferred shares), along with all subsequently       issued shares.[9]  

    4.  Considerations to limit the severity of multiple liquidation preferences:  
(1) capping the returns on preferred shares so that if the company is a modest success, venture capitalists do better by converting preferred shares to common shares than they would by relying on the operation of their liquidation preference; or
(2) a viable compromise might be that the preference operates only against the start-up’s executives. This will leave the investments of other common stock holders (like the executives’ families and friends), proportionally intact.
(3) Liquidation preferences should not:
  1. provide for a “change of control” mechanisms that results in a deemed liquidation in the event of an equity investment involving more than 50% outstanding shares; or
  2. a liquidation preferences should not take effect on a successful exit transactions (for instance, if the company is sold and the valuation received by the sale exceeds a threshold amount). This, along with the other mentioned considerations for liquidation preferences take into account the provision’s objective - to mitigate risk if the company fails, not impair to the rewards of success.[10]
 
      ________________
[1]  Kim Orlesy, “The Difference Between Success and Wisdom With Ryan Blair” (2016), online https://www.kimorlesky.com/blog/author/kim-orlesky
[2] Ryan Blair, “Nothing to Lose, Everything to Gain: How I Went from Gang Member to Multimillionaire Entrepreneur” Portfolio/Penguin (2013).
[3] M. Gorman and W. A. Sahlman, “What Do Venture Capitalists Do?” (1989) 4 J. Bus Venturing 231 at 238.
[4] Well Kenton, “Anti-Dilution Provision” Investopedia (2019), online: <https://www.investopedia.com/terms/a/anti-dilutionprovision.asp>
[5] Bryce C. Tingle, Start-up and Growth Companies in Canada: A Guide to Legal and Business Practices, 3rd ed (Canada: LexisNexis Canada Inc, 2018) at p. 416.
[6] Deepak Malhotra, “How to Negotiate with VCs” (2013) Harvard Business Review, online:  <https://hbr.org/2013/05/how-to-negotiate-with-vcs>
[7] Supra note 5 at p. 419.
[8] Ibid at p. 357.
[9] Ibid.
[10] Ibid at p. 364.
0 Comments



Leave a Reply.

    BVC Blogs

    Blog posts are by students at the Business Venture Clinic. Student bios appear under each post.

    Categories

    All
    ABCA
    Agreements
    Civil Liability
    Confidentiality
    Contractor
    Contracts
    Corporate Structures
    Directors
    Dispute Resolution
    Employee
    Employment Law
    Force Majeur
    Incorporation
    Indemnification
    Jurisdiction
    Licensing
    Non-Compete
    Patents
    Security Interests
    Shareholder Agreement
    Shareholders
    Software
    Startup
    USA
    Warranties

    RSS Feed

    Archives

    April 2025
    March 2025
    February 2025
    December 2024
    November 2024
    May 2024
    April 2024
    March 2024
    February 2024
    January 2024
    December 2023
    November 2023
    October 2023
    April 2023
    March 2023
    February 2023
    January 2023
    November 2022
    October 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    August 2020
    May 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    April 2019
    March 2019
    February 2019
    January 2019
    November 2018
    October 2018
    May 2018
    April 2018
    March 2018
    February 2018
    November 2017
    October 2017
    August 2017

Terms and Conditions | Privacy Statement
 © 2023 University of Calgary. All rights reserved.
  • Home
  • About
  • Clients
  • Resources
    • Links
    • Videos
  • Blog
  • Contact
    • Clinic Schedule